Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Breast Cancer
Related studies linked through entity extraction aliases.
Microbiome and Association With Implant Infections
- Status
- RECRUITING
- Phase
- PHASE2
Life After Breast Cancer - Impact of a Life Coach
- Status
- UNKNOWN
- Phase
- NA
Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy
- Status
- UNKNOWN
- Phase
- N/A
A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation
- Status
- COMPLETED
- Phase
- NA
Patient Recall of Cancer Screening and Diagnosis
- Status
- WITHDRAWN
- Phase
- NA
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Pioglitazone Therapy Targeting Fatigue in Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Digital Phenotyping in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
- Status
- COMPLETED
- Phase
- NA
Prevalence of Depression and Anxiety Among Breast Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)
- Status
- COMPLETED
- Phase
- NA
Insulin Sensitivity After Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Determine the Antitumor Activity of New CAR-macrophages in Breast Cancer Patients' Derived Organoids
- Status
- RECRUITING
- Phase
- N/A
Contrast-Free Magnetic Resonance Imaging for Breast Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Prospective Evaluation of Targeted Axillary Dissection (TAD)
- Status
- COMPLETED
- Phase
- NA
Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2